(Q58282319)

2

0 references

Andrew Hughes

object named as

Andrew Hughes

6

0 references

Caroline Dive

object named as

Caroline Dive

7

0 references

author name string

David J. Moore

1

0 references

Fouziah Butt

3

0 references

Jens Wurthner

4

0 references

Jim Growcott

Clinical Drug Investigation

5

0 references

publication date

March 2012

0 references

published in

0 references

volume

32

0 references

issue

3

0 references

page(s)

179-187

0 references

cites work

Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland.

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Sepsis: redox mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Sepsis: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

APACHE—acute physiology and chronic health evaluation: a physiologically based classification system

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

21 January 2018

12 December 2020

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-alpha antibody afelimomab in patients with sepsis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Biology of interleukin-10 and its regulatory roles in sepsis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Multicenter prospective study of procalcitonin as an indicator of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Procalcitonin as a marker of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Comparison of procalcitonin and C-reactive protein as markers of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Nucleosomes in serum as a marker for cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Cell death in sepsis: a matter of how, when, and where

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Cell death modalities: classification and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Vasopressin versus norepinephrine infusion in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Apoptosis and caspases regulate death and inflammation in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598610-000000000-00000

Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality

21 January 2018

1 reference

12 December 2020

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

1 reference

12 December 2020

Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients

1 reference

12 December 2020

Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

1 reference

12 December 2020

Time course of hemostatic abnormalities in sepsis and its relation to outcome.

1 reference

12 December 2020

Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19

1 reference

12 December 2020

Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis

1 reference

12 December 2020

Procalcitonin in bacterial infections--hype, hope, more or less?

1 reference

12 December 2020